Epidemiologic profile of type-specific human papillomavirus infection after initiation of HPV vaccination
| dc.contributor.author | Sekine, Masayuki | |
| dc.contributor.author | Yamaguchi, Manako | |
| dc.contributor.author | Kudo, Risa | |
| dc.contributor.author | Hanley, Sharon J.B. | |
| dc.contributor.author | Hara, Megumi | |
| dc.contributor.author | Adachi, Sosuke | |
| dc.contributor.author | Ueda, Yutaka | |
| dc.contributor.author | Miyagi, Etsuko | |
| dc.contributor.author | Ikeda, Sayaka | |
| dc.contributor.author | Yagi, Asami | |
| dc.contributor.author | Enomoto, Takayuki | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.date.accessioned | 2023-04-26T09:37:00Z | |
| dc.date.available | 2023-04-26T09:37:00Z | |
| dc.date.issued | 2020-09-01 | |
| dc.description | Funding Information: This work was supported by the Health and Labor Sciences Research Grant [26272001] and the Japanese Agency for Medical Research and Development [JP15ck0106103]. Acknowledgments: We would like to thank Yuka Watanabe, Sachiko Ono, Anna Ishida, Yoko Motoki and the administrator of Niigata city for their support in conducting the survey | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 892308 | |
| dc.identifier | 235112635 | |
| dc.identifier | 24f8c237-f053-4411-9dcc-878267a2ffe6 | |
| dc.identifier | 85089120920 | |
| dc.identifier.citation | Sekine, M, Yamaguchi, M, Kudo, R, Hanley, S J B, Hara, M, Adachi, S, Ueda, Y, Miyagi, E, Ikeda, S, Yagi, A & Enomoto, T 2020, 'Epidemiologic profile of type-specific human papillomavirus infection after initiation of HPV vaccination', Vaccines, vol. 8, no. 3, 425, pp. 1-8. https://doi.org/10.3390/vaccines8030425 | en |
| dc.identifier.doi | 10.3390/vaccines8030425 | |
| dc.identifier.iss | 3 | en |
| dc.identifier.issn | 2076-393X | |
| dc.identifier.other | ORCID: /0000-0002-7554-004X/work/133803541 | |
| dc.identifier.uri | https://hdl.handle.net/2164/20563 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85089120920&partnerID=8YFLogxK | en |
| dc.identifier.vol | 8 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Vaccines | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Cross-protection | en |
| dc.subject | HPV infection | en |
| dc.subject | HPV vaccine | en |
| dc.subject | Type replacement | en |
| dc.subject | R Medicine | en |
| dc.subject | Immunology | en |
| dc.subject | Pharmacology | en |
| dc.subject | Drug Discovery | en |
| dc.subject | Infectious Diseases | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject.lcc | R | en |
| dc.title | Epidemiologic profile of type-specific human papillomavirus infection after initiation of HPV vaccination | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Sekine_etal_V_Epidemiologic_Profile_Of_VoR.pdf
- Size:
- 871.39 KB
- Format:
- Adobe Portable Document Format
